Drug Shortage Report for TEVA-CANDESARTAN
| Report ID | 217237 |
| Drug Identification Number | 02366339 |
| Brand name | TEVA-CANDESARTAN |
| Common or Proper name | CANDESARTAN 32MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CANDESARTAN CILEXETIL |
| Strength(s) | 32MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | pp 30 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-24 |
| Estimated end date | 2024-02-20 |
| Actual end date | 2024-02-07 |
| Shortage status | Resolved |
| Updated date | 2024-02-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-02-08 | French | Compare |
| v3 | 2024-02-08 | English | Compare |
| v2 | 2024-01-25 | French | Compare |
| v1 | 2024-01-25 | English | Compare |
Showing 1 to 4 of 4